Key Quantitative Figures

  • Total monetary impact quantifiable: ₹17,46,026/-
  • This amount includes Penalty under Section 270A(9) read with Section 270A(8) of the Income Tax Act, 1961

Dates of Action

  • Date of receipt of order: 18th June, 2026 at 23:29 Hrs (IST)
  • Date of disclosure to exchanges: 19th June, 2026

Parties Involved

  • Issuing Authority: Income Tax Department, Assessment Unit
  • Listed Entity: Anuh Pharma Limited
  • Disclosure signed by: Manan Vadhan, Company Secretary & Compliance Officer

Nature of Violation

Penalty Order under section 270A issued on account of disallowances of certain deductions claimed under various provisions of the Income Tax Act. The matter relates to Scrutiny Assessment for Assessment Year 2020-21.

Financial Impact and Company Stance

  • Quantifiable monetary impact: ₹17,46,026/-
  • The company is in the process of filing an appeal against the order within prescribed timelines
  • The company believes it has adequate factual and legal grounds to reasonably substantiate its position
  • Company states: "As such, there is no impact on financial operations or other activities of the Company"

Additional Information

  • BSE Scrip Code: 506260
  • NSE Symbol: ANUHPHR; Series: EQ
  • Disclosure also uploaded on company website: www.anuhpharma.com
  • Signed digitally by Manan Jayesh Vadhan, Company Secretary & Compliance Officer on 2026.06.19 at 17:10:27 +05'30'
  • Place of signing: Mumbai